- Horizons and Jerusalem-based OurCrowd lead US$24 million Series B funding round
- Funding will go towards the expansion of a third-phase clinical trial of a nasal spray aimed at treating and preventing Covid-19
Read more here.
[SaNOtize in South China Morning Post] Li Ka-shing’s Horizons Ventures makes undisclosed investment in Canadian Covid-19 treatment start-up SaNOtize
Date:
Latest Intelligence
